Get Premium to unlock powerful stock data

Eventide Asset Management, Llc Buys DICE Therapeutics Inc, Five9 Inc, Xometry Inc, Sells Biohaven Pharmaceutical Holding Co, RingCentral Inc, BridgeBio Pharma Inc

Author's Avatar
insider
Nov 16, 2021
Article's Main Image
Boston, MA, based Investment company Eventide Asset Management, Llc (Current Portfolio) buys DICE Therapeutics Inc, Five9 Inc, Xometry Inc, Global E Online, Fiverr International, sells Biohaven Pharmaceutical Holding Co, RingCentral Inc, BridgeBio Pharma Inc, Trillium Therapeutics Inc, Celldex Therapeutics Inc during the 3-months ended 2021Q3, according to the most recent filings of the investment company, Eventide Asset Management, Llc. As of 2021Q3, Eventide Asset Management, Llc owns 150 stocks with a total value of $7.6 billion. These are the details of the buys and sells.

For the details of EVENTIDE ASSET MANAGEMENT, LLC's stock buys and sells, go to https://www.gurufocus.com/guru/eventide+asset+management%2C+llc/current-portfolio/portfolio

These are the top 5 holdings of EVENTIDE ASSET MANAGEMENT, LLC
  1. Ascendis Pharma A/S (ASND) - 1,748,648 shares, 3.69% of the total portfolio. Shares added by 2.94%
  2. Five9 Inc (FIVN) - 1,469,015 shares, 3.10% of the total portfolio. Shares added by 24.44%
  3. CrowdStrike Holdings Inc (CRWD) - 793,285 shares, 2.58% of the total portfolio. Shares reduced by 11%
  4. Dynatrace Inc (DT) - 2,737,908 shares, 2.57% of the total portfolio. Shares added by 0.28%
  5. The Trade Desk Inc (TTD) - 2,756,430 shares, 2.56% of the total portfolio.
New Purchase: DICE Therapeutics Inc (DICE)

Eventide Asset Management, Llc initiated holding in DICE Therapeutics Inc. The purchase prices were between $31.92 and $37, with an estimated average price of $34.06. The stock is now traded at around $34.150000. The impact to a portfolio due to this purchase was 0.78%. The holding were 1,871,612 shares as of 2021-09-30.

New Purchase: Global E Online Ltd (GLBE)

Eventide Asset Management, Llc initiated holding in Global E Online Ltd. The purchase prices were between $53.49 and $81.69, with an estimated average price of $67.58. The stock is now traded at around $63.910000. The impact to a portfolio due to this purchase was 0.45%. The holding were 478,198 shares as of 2021-09-30.

New Purchase: DLocal Ltd (DLO)

Eventide Asset Management, Llc initiated holding in DLocal Ltd. The purchase prices were between $42.6 and $69, with an estimated average price of $55.93. The stock is now traded at around $47.000000. The impact to a portfolio due to this purchase was 0.36%. The holding were 505,047 shares as of 2021-09-30.

New Purchase: Coursera Inc (COUR)

Eventide Asset Management, Llc initiated holding in Coursera Inc. The purchase prices were between $30.92 and $43.31, with an estimated average price of $37.71. The stock is now traded at around $36.540000. The impact to a portfolio due to this purchase was 0.33%. The holding were 800,000 shares as of 2021-09-30.

New Purchase: Guardant Health Inc (GH)

Eventide Asset Management, Llc initiated holding in Guardant Health Inc. The purchase prices were between $98.77 and $132.17, with an estimated average price of $119.09. The stock is now traded at around $105.230000. The impact to a portfolio due to this purchase was 0.29%. The holding were 178,000 shares as of 2021-09-30.

New Purchase: VectivBio Holding AG (VECT)

Eventide Asset Management, Llc initiated holding in VectivBio Holding AG. The purchase prices were between $6.7 and $11.54, with an estimated average price of $8.6. The stock is now traded at around $4.825000. The impact to a portfolio due to this purchase was 0.23%. The holding were 2,339,044 shares as of 2021-09-30.

Added: Five9 Inc (FIVN)

Eventide Asset Management, Llc added to a holding in Five9 Inc by 24.44%. The purchase prices were between $158.23 and $209.7, with an estimated average price of $182.37. The stock is now traded at around $166.520000. The impact to a portfolio due to this purchase was 0.61%. The holding were 1,469,015 shares as of 2021-09-30.

Added: Xometry Inc (XMTR)

Eventide Asset Management, Llc added to a holding in Xometry Inc by 4852.01%. The purchase prices were between $53.99 and $81.35, with an estimated average price of $69.33. The stock is now traded at around $51.210000. The impact to a portfolio due to this purchase was 0.56%. The holding were 742,802 shares as of 2021-09-30.

Added: Fiverr International Ltd (FVRR)

Eventide Asset Management, Llc added to a holding in Fiverr International Ltd by 29.08%. The purchase prices were between $161.38 and $258.6, with an estimated average price of $201.76. The stock is now traded at around $181.520000. The impact to a portfolio due to this purchase was 0.38%. The holding were 696,962 shares as of 2021-09-30.

Added: Agilent Technologies Inc (A)

Eventide Asset Management, Llc added to a holding in Agilent Technologies Inc by 112.46%. The purchase prices were between $147.58 and $179.28, with an estimated average price of $161.83. The stock is now traded at around $161.390000. The impact to a portfolio due to this purchase was 0.35%. The holding were 322,300 shares as of 2021-09-30.

Added: Allakos Inc (ALLK)

Eventide Asset Management, Llc added to a holding in Allakos Inc by 57.11%. The purchase prices were between $76.53 and $110.43, with an estimated average price of $89.41. The stock is now traded at around $82.000000. The impact to a portfolio due to this purchase was 0.32%. The holding were 630,000 shares as of 2021-09-30.

Added: Hannon Armstrong Sustainable Infrastructure Capita (HASI)

Eventide Asset Management, Llc added to a holding in Hannon Armstrong Sustainable Infrastructure Capita by 37.67%. The purchase prices were between $53.48 and $61.25, with an estimated average price of $57.07. The stock is now traded at around $62.410000. The impact to a portfolio due to this purchase was 0.19%. The holding were 964,000 shares as of 2021-09-30.

Sold Out: BridgeBio Pharma Inc (BBIO)

Eventide Asset Management, Llc sold out a holding in BridgeBio Pharma Inc. The sale prices were between $46.87 and $64.24, with an estimated average price of $53.73.

Sold Out: Xenon Pharmaceuticals Inc (XENE)

Eventide Asset Management, Llc sold out a holding in Xenon Pharmaceuticals Inc. The sale prices were between $14.86 and $19.45, with an estimated average price of $17.41.

Sold Out: ALX Oncology Holdings Inc (ALXO)

Eventide Asset Management, Llc sold out a holding in ALX Oncology Holdings Inc. The sale prices were between $52.51 and $80.91, with an estimated average price of $66.57.

Sold Out: Sotera Health Co (SHC)

Eventide Asset Management, Llc sold out a holding in Sotera Health Co. The sale prices were between $22.25 and $26.52, with an estimated average price of $24.22.

Sold Out: Keros Therapeutics Inc (KROS)

Eventide Asset Management, Llc sold out a holding in Keros Therapeutics Inc. The sale prices were between $29.27 and $43.71, with an estimated average price of $35.63.

Sold Out: Equinix Inc (EQIX)

Eventide Asset Management, Llc sold out a holding in Equinix Inc. The sale prices were between $786.38 and $882.83, with an estimated average price of $831.05.



Here is the complete portfolio of EVENTIDE ASSET MANAGEMENT, LLC. Also check out:

1. EVENTIDE ASSET MANAGEMENT, LLC's Undervalued Stocks
2. EVENTIDE ASSET MANAGEMENT, LLC's Top Growth Companies, and
3. EVENTIDE ASSET MANAGEMENT, LLC's High Yield stocks
4. Stocks that EVENTIDE ASSET MANAGEMENT, LLC keeps buying
Rating:
NaN / 5 ( votes)
Author's Avatar
WRITTEN BY

GuruFocus Screeners

Related Articles

Q&A with Gurus